Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Jun;33(6):987–988. doi: 10.1128/aac.33.6.987

Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever.

F Gudiol 1, R Pallares 1, J Carratala 1, F Bolao 1, J Ariza 1, G Rufi 1, P F Viladrich 1
PMCID: PMC284272  PMID: 2669629

Abstract

A study of 43 patients with Mediterranean spotted fever showed that a 2-day course of ciprofloxacin or a 2-day course of doxycycline may be an effective mode of therapy. All patients in both arms of the study were cured; however, doxycycline produced a more rapid defervescence.

Full text

PDF
987

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bella-Cueto F., Font-Creus B., Segura-Porta F., Espejo-Arenas E., López-Parés P., Muñoz-Espín T. Comparative, randomized trial of one-day doxycycline versus 10-day tetracycline therapy for Mediterranean spotted fever. J Infect Dis. 1987 May;155(5):1056–1058. doi: 10.1093/infdis/155.5.1056. [DOI] [PubMed] [Google Scholar]
  2. Edlinger E. Serological diagnosis of Mediterranean spotted fever. Ann Microbiol (Paris) 1979 Feb-Mar;130(2):203–211. [PubMed] [Google Scholar]
  3. Font-Creus B., Bella-Cueto F., Espejo-Arenas E., Vidal-Sanahuja R., Muñoz-Espin T., Nolla-Salas M., Casagran-Borrell A., Mercade-Cuesta J., Segura-Porta F. Mediterranean spotted fever: a cooperative study of 227 cases. Rev Infect Dis. 1985 Sep-Oct;7(5):635–642. doi: 10.1093/clinids/7.5.635. [DOI] [PubMed] [Google Scholar]
  4. Lambert M., Dugernier T., Bigaignon G., Rahier J., Piot P. Mediterranean spotted fever in Belgium. Lancet. 1984 Nov 3;2(8410):1038–1038. doi: 10.1016/s0140-6736(84)91133-4. [DOI] [PubMed] [Google Scholar]
  5. Raoult D., Gallais H., De Micco P., Casanova P. Ciprofloxacin therapy for Mediterranean spotted fever. Antimicrob Agents Chemother. 1986 Oct;30(4):606–607. doi: 10.1128/aac.30.4.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Raoult D., Gallais H., Ottomani A., Resch J. P., Tichadou D., De Micco P., Casanova P. La forme maligne de la fièvre boutonneuse méditerranéenne. Six observations. Presse Med. 1983 Oct 29;12(38):2375–2378. [PubMed] [Google Scholar]
  7. Raoult D., Roussellier P., Galicher V., Perez R., Tamalet J. In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay. Antimicrob Agents Chemother. 1986 Mar;29(3):424–425. doi: 10.1128/aac.29.3.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Raoult D., Weiller P. J., Chagnon A., Chaudet H., Gallais H., Casanova P. Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases. Am J Trop Med Hyg. 1986 Jul;35(4):845–850. doi: 10.4269/ajtmh.1986.35.845. [DOI] [PubMed] [Google Scholar]
  9. Schlaeffer F., Lederer K., Mates S. M. Mediterranean spotted fever in an American woman. Arch Intern Med. 1985 Sep;145(9):1733–1734. [PubMed] [Google Scholar]
  10. Staszewski S., Helm E. B., Stille W. Autochthonic Mediterranean spotted fever in West Germany. Lancet. 1984 Dec 22;2(8417-8418):1466–1466. doi: 10.1016/s0140-6736(84)91652-0. [DOI] [PubMed] [Google Scholar]
  11. Thadepalli H., Bansal M. B., Rao B., See R., Chuah S. K., Marshall R., Dhawan V. K. Ciprofloxacin: in vitro, experimental, and clinical evaluation. Rev Infect Dis. 1988 May-Jun;10(3):505–515. doi: 10.1093/clinids/10.3.505. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES